This $1,473,430 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research on pluripotent stem cell-derived corneal endothelial cells for the treatment of combat laser-induced corneal edema and vision restoration. Spanning from September 1, 2024 to August 31, 2027, this award will enable Johns Hopkins to conduct innovative biomedical research to develop new treatments for military personnel impacted by combat-related eye injuries. The project aims to leverage stem cell technology to restore corneal function and visual acuity. As a leading research university with extensive federal contracting and grant experience, Johns Hopkins is well-positioned to deliver on the research objectives of this critical military medical initiative.
Generated 4/1/25, 3:20 AM